Sei sulla pagina 1di 10

43. Fisher D, Heymann D (February 2020).

"Q&A: The novel coronavirus outbreak causing


COVID-19" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047369). BMC Medicine. 18 (1):
57. doi:10.1186/s12916-020-01533-w (https://doi.org/10.1186%2Fs12916-020-01533-w).
PMC 7047369 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047369). PMID 32106852 (htt
ps://pubmed.ncbi.nlm.nih.gov/32106852).
44. Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. (May 2020). "Clinical characteristics of
novel coronavirus cases in tertiary hospitals in Hubei Province" (https://www.ncbi.nlm.nih.gov/p
mc/articles/PMC7147277). Chinese Medical Journal. 133 (9): 1025–1031.
doi:10.1097/CM9.0000000000000744 (https://doi.org/10.1097%2FCM9.0000000000000744).
PMC 7147277 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147277). PMID 32044814 (htt
ps://pubmed.ncbi.nlm.nih.gov/32044814).
45. Wang T, Du Z, Zhu F, Cao Z, An Y, Gao Y, Jiang B (March 2020). "Comorbidities and multi-
organ injuries in the treatment of COVID-19". Lancet. Elsevier BV. 395 (10228): e52.
doi:10.1016/s0140-6736(20)30558-4 (https://doi.org/10.1016%2Fs0140-6736%2820%293055
8-4). PMID 32171074 (https://pubmed.ncbi.nlm.nih.gov/32171074).
46. Henry BM (April 2020). "COVID-19, ECMO, and lymphopenia: a word of caution" (https://www.
ncbi.nlm.nih.gov/pmc/articles/PMC7118650). The Lancet. Respiratory Medicine. Elsevier BV. 8
(4): e24. doi:10.1016/s2213-2600(20)30119-3 (https://doi.org/10.1016%2Fs2213-2600%282
0%2930119-3). PMC 7118650 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118650).
PMID 32178774 (https://pubmed.ncbi.nlm.nih.gov/32178774).
47. Wang L, Wang Y, Ye D, Liu Q (March 2020). "Review of the 2019 novel coronavirus (SARS-
CoV-2) based on current evidence" (https://www.sciencedirect.com/science/article/pii/S092485
7920300984). International Journal of Antimicrobial Agents: 105948.
doi:10.1016/j.ijantimicag.2020.105948 (https://doi.org/10.1016%2Fj.ijantimicag.2020.105948).
PMC 7156162 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156162). PMID 32201353 (htt
ps://pubmed.ncbi.nlm.nih.gov/32201353). Archived (https://web.archive.org/web/20200327232
545/https://www.sciencedirect.com/science/article/pii/S0924857920300984) from the original
on 27 March 2020. Retrieved 27 March 2020.
48. Wang Y, Wang Y, Chen Y, Qin Q (March 2020). "Unique epidemiological and clinical features
of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control
measures" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228347). Journal of Medical
Virology. n/a (n/a): 568–576. doi:10.1002/jmv.25748 (https://doi.org/10.1002%2Fjmv.25748).
PMC 7228347 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228347). PMID 32134116 (htt
ps://pubmed.ncbi.nlm.nih.gov/32134116).
49. Cheng ZJ, Shan J (April 2020). "2019 Novel coronavirus: where we are and what we know" (ht
tps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095345). Infection. 48 (2): 155–163.
doi:10.1007/s15010-020-01401-y (https://doi.org/10.1007%2Fs15010-020-01401-y).
PMC 7095345 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095345). PMID 32072569 (htt
ps://pubmed.ncbi.nlm.nih.gov/32072569).
50. "Clinical management of severe acute respiratory infection when novel coronavirus (nCoV)
infection is suspected" (https://www.who.int/publications-detail/clinical-management-of-severe-
acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected). World
Health Organization (WHO). Archived (https://web.archive.org/web/20200131032122/https://w
ww.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when
-novel-coronavirus-(ncov)-infection-is-suspected) from the original on 31 January 2020.
Retrieved 13 February 2020.
51. Farkas J (March 2020). COVID-19—The Internet Book of Critical Care (https://emcrit.org/ibcc/c
ovid19/) (digital) (Reference manual). USA: EMCrit. Archived (https://web.archive.org/web/202
00311195758/https://emcrit.org/ibcc/covid19/) from the original on 11 March 2020. Retrieved
13 March 2020.
52. "COVID19—Resources for Health Care Professionals" (https://guides.library.upenn.edu/covid-
19). Penn Libraries. 11 March 2020. Archived (https://web.archive.org/web/20200314035631/h
ttps://guides.library.upenn.edu/covid-19) from the original on 14 March 2020. Retrieved
13 March 2020.
53. "Frequently Asked Questions on the Emergency Use Authorization for Remdesivir for Certain
Hospitalized COVID‐19 Patients" (https://www.fda.gov/media/137574/download) (PDF). U.S.
Food and Drug Administration (FDA). 1 May 2020. Retrieved 1 May 2020. This article
incorporates text from this source, which is in the public domain.
54. Day M (March 2020). "Covid-19: ibuprofen should not be used for managing symptoms, say
doctors and scientists" (https://www.bmj.com/content/368/bmj.m1086). BMJ. 368: m1086.
doi:10.1136/bmj.m1086 (https://doi.org/10.1136%2Fbmj.m1086). PMID 32184201 (https://pub
med.ncbi.nlm.nih.gov/32184201). Archived (https://web.archive.org/web/20200319181945/http
s://www.bmj.com/content/368/bmj.m1086) from the original on 19 March 2020. Retrieved
18 March 2020.
55. "Self-isolation advice—Coronavirus (COVID-19)" (https://www.nhs.uk/conditions/coronavirus-c
ovid-19/self-isolation-advice/). National Health Service (United Kingdom). 28 February 2020.
Archived (https://web.archive.org/web/20200328000128/https://www.nhs.uk/conditions/corona
virus-covid-19/self-isolation-advice/) from the original on 28 March 2020. Retrieved 27 March
2020.
56. Godoy M (18 March 2020). "Concerned About Taking Ibuprofen For Coronavirus Symptoms?
Here's What Experts Say" (https://www.npr.org/sections/health-shots/2020/03/18/818026613/a
dvice-from-france-to-avoid-ibuprofen-for-covid-19-leaves-experts-baffled). NPR. Retrieved
8 April 2020.
57. AFP (19 March 2020). "Updated: WHO Now Doesn't Recommend Avoiding Ibuprofen For
COVID-19 Symptoms" (https://www.sciencealert.com/who-recommends-to-avoid-taking-ibupro
fen-for-covid-19-symptoms). ScienceAlert. Archived (https://web.archive.org/web/2020031822
2020/https://www.sciencealert.com/who-recommends-to-avoid-taking-ibuprofen-for-covid-19-sy
mptoms) from the original on 18 March 2020. Retrieved 19 March 2020.
58. Research, Center for Drug Evaluation and (19 March 2020). "FDA advises patients on use of
non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19" (https://www.fda.gov/drugs/dru
g-safety-and-availability/fda-advises-patients-use-non-steroidal-anti-inflammatory-drugs-nsaids
-covid-19). Drug Safety and Availability. Archived (https://web.archive.org/web/2020032719463
3/https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-patients-use-non-steroidal
-anti-inflammatory-drugs-nsaids-covid-19) from the original on 27 March 2020. Retrieved
27 March 2020.
59. "Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless
otherwise advised by their physician" (https://web.archive.org/web/20200321172112/https://ww
w.hfsa.org/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unl
ess-otherwise-advised-by-their-physician/). Archived from the original (https://www.hfsa.org/pat
ients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise
-advised-by-their-physician/) on 21 March 2020. Retrieved 21 March 2020.
60. "Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless
otherwise advised by their physician" (https://newsroom.heart.org/news/patients-taking-ace-i-a
nd-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-p
hysician). American Heart Association (Press release). 17 March 2020. Archived (https://web.a
rchive.org/web/20200324050912/https://newsroom.heart.org/news/patients-taking-ace-i-and-ar
bs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physici
an) from the original on 24 March 2020. Retrieved 25 March 2020.
61. de Simone G. "Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and
Angiotensin Receptor Blockers" (https://www.escardio.org/Councils/Council-on-Hypertension-
(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-
ang). Council on Hypertension of the European Society of Cardiology. Archived (https://web.ar
chive.org/web/20200324073257/https://www.escardio.org/Councils/Council-on-Hypertension-
(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang)
from the original on 24 March 2020. Retrieved 24 March 2020.
62. "New Evidence Concerning Safety of ACE Inhibitors, ARBs in COVID-19" (https://www.pharma
cytimes.com/news/new-evidence-concerning-safety-of-ace-inhibitors-arbs-in-covid-19).
Pharmacy Times. Retrieved 2 May 2020.
63. Vetter P, Eckerle I, Kaiser L (February 2020). "Covid-19: a puzzle with many missing pieces".
BMJ. 368: m627. doi:10.1136/bmj.m627 (https://doi.org/10.1136%2Fbmj.m627).
PMID 32075791 (https://pubmed.ncbi.nlm.nih.gov/32075791).
64. "Novel Coronavirus—COVID-19: What Emergency Clinicians Need to Know" (https://www.ebm
edicine.net/topics/infectious-disease/COVID-19). www.ebmedicine.net. Archived (https://web.a
rchive.org/web/20200314163512/https://www.ebmedicine.net/topics/infectious-disease/COVID
-19) from the original on 14 March 2020. Retrieved 9 March 2020.
65. Tang N, Bai H, Chen X, Gong J, Li D, Sun Z (May 2020). "Anticoagulant treatment is
associated with decreased mortality in severe coronavirus disease 2019 patients with
coagulopathy". Journal of Thrombosis and Haemostasis. 18 (5): 1094–1099.
doi:10.1111/jth.14817 (https://doi.org/10.1111%2Fjth.14817). PMID 32220112 (https://pubme
d.ncbi.nlm.nih.gov/32220112).
66. "Sequence for Putting On Personal Protective Equipment (PPE)" (https://www.cdc.gov/hai/pdf
s/ppe/PPE-Sequence.pdf) (PDF). Centers for Disease Control and Prevention (CDC). Archived
(https://web.archive.org/web/20200305173617/https://www.cdc.gov/hai/pdfs/ppe/ppe-sequenc
e.pdf) (PDF) from the original on 5 March 2020. Retrieved 8 March 2020.
67. Cheung JC, Ho LT, Cheng JV, Cham EY, Lam KN (April 2020). "Staff safety during emergency
airway management for COVID-19 in Hong Kong" (https://www.ncbi.nlm.nih.gov/pmc/articles/P
MC7128208). The Lancet. Respiratory Medicine. 8 (4): e19. doi:10.1016/s2213-
2600(20)30084-9 (https://doi.org/10.1016%2Fs2213-2600%2820%2930084-9). PMC 7128208
(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128208). PMID 32105633 (https://pubmed.nc
bi.nlm.nih.gov/32105633).
68. "What healthcare personnel should know about caring for patients with confirmed or possible
coronavirus disease 2" (https://www.cdc.gov/coronavirus/2019-ncov/hcp/caring-for-patients-H.
pdf) (PDF). Centers for Disease Control and Prevention (CDC). 12 March 2020. Retrieved
31 March 2020.
69. "Coronavirus Disease 2019 (COVID-19)" (https://www.cdc.gov/coronavirus/2019-ncov/infection
-control/control-recommendations.html). Centers for Disease Control and Prevention (CDC).
11 February 2020. Archived (https://web.archive.org/web/20200304165907/https://www.cdc.go
v/coronavirus/2019-ncov/infection-control/control-recommendations.html) from the original on 4
March 2020. Retrieved 11 March 2020.
70. "Coronavirus Disease 2019 (COVID-19)" (https://www.cdc.gov/coronavirus/2019-ncov/hcp/cari
ng-for-patients.html). Centers for Disease Control and Prevention (CDC). 11 February 2020.
Archived (https://web.archive.org/web/20200304165907/https://www.cdc.gov/coronavirus/2019
-ncov/hcp/caring-for-patients.html) from the original on 4 March 2020. Retrieved 8 March 2020.
71. "Interim Infection Prevention and Control Recommendations for Patients with Suspected or
Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings" (https://www.cdc.go
v/coronavirus/2019-ncov/infection-control/control-recommendations.html). Centers for Disease
Control and Prevention (CDC). 11 February 2020. Archived (https://web.archive.org/web/2020
0304165907/https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommenda
tions.html) from the original on 4 March 2020. Retrieved 25 March 2020.
72. "Coronavirus Disease 2019 (COVID-19) Frequently Asked Questions" (https://www.fda.gov/em
ergency-preparedness-and-response/mcm-issues/coronavirus-disease-2019-covid-19-frehttp
s://oc.wikipedia.org/wiki/Malauti%C3%A1_de_coronavirus_de_2019quently-asked-questions#
5e78ba94b86da). Food and Drug Administration.
73. "Strategies for Optimizing the Supply of Facemasks" (https://www.cdc.gov/coronavirus/2019-nc
ov/hcp/ppe-strategy/face-masks.html). Centers for Disease Control and Prevention (CDC). 11
February 2020. Archived (https://web.archive.org/web/20200323173927/https://www.cdc.gov/c
oronavirus/2019-ncov/hcp/ppe-strategy/face-masks.html) from the original on 23 March 2020.
Retrieved 23 March 2020.
74. Murthy S, Gomersall CD, Fowler RA (March 2020). "Care for Critically Ill Patients With COVID-
19" (https://jamanetwork.com/journals/jama/fullarticle/2762996). JAMA. 323 (15): 1499.
doi:10.1001/jama.2020.3633 (https://doi.org/10.1001%2Fjama.2020.3633). PMID 32159735 (h
ttps://pubmed.ncbi.nlm.nih.gov/32159735). Archived (https://web.archive.org/web/2020031820
3852/https://jamanetwork.com/journals/jama/fullarticle/2762996) from the original on 18 March
2020. Retrieved 18 March 2020.
75. World Health Organization (28 January 2020). "Clinical management of severe acute
respiratory infection when novel coronavirus (2019-nCoV) infection is suspected" (https://www.
who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf) (PDF).
Archived (https://web.archive.org/web/20200226041620/https://www.who.int/docs/default-sour
ce/coronaviruse/clinical-management-of-novel-cov.pdf) (PDF) from the original on 26 February
2020. Retrieved 18 March 2020.
76. Wang K, Zhao W, Li J, Shu W, Duan J (March 2020). "The experience of high-flow nasal
cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two
hospitals of Chongqing, China" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104710).
Annals of Intensive Care. 10 (1): 37. doi:10.1186/s13613-020-00653-z (https://doi.org/10.118
6%2Fs13613-020-00653-z). PMC 7104710 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC71
04710). PMID 32232685 (https://pubmed.ncbi.nlm.nih.gov/32232685).
77. McEnery T, Gough C, Costello RW (April 2020). "COVID-19: Respiratory support outside the
intensive care unit" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146718). The Lancet.
Respiratory Medicine. doi:10.1016/S2213-2600(20)30176-4 (https://doi.org/10.1016%2FS2213
-2600%2820%2930176-4). PMC 7146718 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC714
6718). PMID 32278367 (https://pubmed.ncbi.nlm.nih.gov/32278367).
78. Cummings, Matthew J.; Baldwin, Matthew R.; Abrams, Darryl; Jacobson, Samuel D.; Meyer,
Benjamin J.; Balough, Elizabeth M.; Aaron, Justin G.; Claassen, Jan; Rabbani, LeRoy E.;
Hastie, Jonathan; Hochman, Beth R. (19 May 2020). "Epidemiology, clinical course, and
outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study" (ht
tps://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31189-2/abstract). The
Lancet. 0. doi:10.1016/S0140-6736(20)31189-2 (https://doi.org/10.1016%2FS0140-6736%282
0%2931189-2). ISSN 0140-6736 (https://www.worldcat.org/issn/0140-6736).
79. Scott, Dylan (16 March 2020). "Coronavirus is exposing all of the weaknesses in the US health
system High health care costs and low medical capacity made the US uniquely vulnerable to
the coronavirus" (https://www.vox.com/policy-and-politics/2020/3/16/21173766/coronavirus-cov
id-19-us-cases-health-care-system). Vox. Archived (https://web.archive.org/web/20200318022
237/https://www.vox.com/policy-and-politics/2020/3/16/21173766/coronavirus-covid-19-us-cas
es-health-care-system) from the original on 18 March 2020. Retrieved 18 March 2020.
80. Matthay MA, Aldrich JM, Gotts JE (May 2020). "Treatment for severe acute respiratory distress
syndrome from COVID-19" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118607). The
Lancet. Respiratory Medicine. 8 (5): 433–434. doi:10.1016/S2213-2600(20)30127-2 (https://do
i.org/10.1016%2FS2213-2600%2820%2930127-2). PMC 7118607 (https://www.ncbi.nlm.nih.g
ov/pmc/articles/PMC7118607). PMID 32203709 (https://pubmed.ncbi.nlm.nih.gov/32203709).
81. Briel M, Meade M, Mercat A, Brower RG, Talmor D, Walter SD, et al. (March 2010). "Higher vs
lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory
distress syndrome: systematic review and meta-analysis". JAMA. 303 (9): 865–73.
doi:10.1001/jama.2010.218 (https://doi.org/10.1001%2Fjama.2010.218). PMID 20197533 (http
s://pubmed.ncbi.nlm.nih.gov/20197533).
82. Diaz R, Heller D (2020). Barotrauma And Mechanical Ventilation (https://www.ncbi.nlm.nih.gov/
books/NBK545226/). StatPearls. StatPearls Publishing. PMID 31424810 (https://pubmed.ncbi.
nlm.nih.gov/31424810).
83. "Chinese doctors using plasma therapy on coronavirus, WHO says 'very valid' approach" (http
s://www.reuters.com/article/us-china-health-hospital-idUSKBN20B1M6). Reuters. 17 February
2020. Archived (https://web.archive.org/web/20200304173709/https://www.reuters.com/article/
us-china-health-hospital-idUSKBN20B1M6) from the original on 4 March 2020. Retrieved
19 March 2020.
84. Steenhuysen J, Kelland K (24 January 2020). "With Wuhan virus genetic code in hand,
scientists begin work on a vaccine" (https://www.reuters.com/article/us-china-health-vaccines-i
dUSKBN1ZN2J8). Reuters. Archived (https://web.archive.org/web/20200125203723/https://ww
w.reuters.com/article/us-china-health-vaccines-idUSKBN1ZN2J8) from the original on 25
January 2020. Retrieved 25 January 2020.
85. Duddu P (19 February 2020). "Coronavirus outbreak: Vaccines/drugs in the pipeline for Covid-
19" (https://web.archive.org/web/20200219184512/https://www.clinicaltrialsarena.com/analysi
s/coronavirus-mers-cov-drugs/). clinicaltrialsarena.com. Archived from the original (https://ww
w.clinicaltrialsarena.com/analysis/coronavirus-mers-cov-drugs/) on 19 February 2020.
86. Lu H (March 2020). "Drug treatment options for the 2019-new coronavirus (2019-nCoV)".
Bioscience Trends. 14 (1): 69–71. doi:10.5582/bst.2020.01020 (https://doi.org/10.5582%2Fbst.
2020.01020). PMID 31996494 (https://pubmed.ncbi.nlm.nih.gov/31996494).
87. Li G, De Clercq E (March 2020). "Therapeutic options for the 2019 novel coronavirus (2019-
nCoV)". Nature Reviews. Drug Discovery. 19 (3): 149–150. doi:10.1038/d41573-020-00016-0
(https://doi.org/10.1038%2Fd41573-020-00016-0). PMID 32127666 (https://pubmed.ncbi.nlm.n
ih.gov/32127666).
88. Nebehay S, Kelland K, Liu R (5 February 2020). "WHO: 'no known effective' treatments for
new coronavirus" (https://www.reuters.com/article/us-china-health-treatments-who-idUSKBN1Z
Z1M6). Thomson Reuters. Archived (https://web.archive.org/web/20200205155653/https://ww
w.reuters.com/article/us-china-health-treatments-who-idUSKBN1ZZ1M6) from the original on 5
February 2020. Retrieved 5 February 2020.
89. "Blood plasma taken from covid-19 survivors might help patients fight off the disease" (https://
www.technologyreview.com/2020/04/08/998700/blood-plasma-taken-from-covid-19-survivors-
might-help-patients-fight-it-off/). MIT Technology Review.
90. "Trials of Plasma From Recovered Covid-19 Patients Have Begun" (https://www.wired.com/sto
ry/trials-of-plasma-from-recovered-covid-19-patients-have-begun/). Wired.
91. "FDA now allows treatment of life-threatening COVID-19 cases using blood from patients who
have recovered" (https://social.techcrunch.com/2020/03/24/fda-now-allows-treatment-of-life-thr
eatening-covid-19-cases-using-blood-from-patients-who-have-recovered/). TechCrunch.
Retrieved 9 April 2020.
92. "China launches coronavirus 'close contact' app" (https://www.bbc.com/news/technology-5143
9401). BBC News. 11 February 2020. Archived (https://web.archive.org/web/2020022800395
7/https://www.bbc.com/news/technology-51439401) from the original on 28 February 2020.
Retrieved 7 March 2020.
93. Chen A. "China's coronavirus app could have unintended consequences" (https://www.technol
ogyreview.com/s/615199/coronavirus-china-app-close-contact-surveillance-covid-19-technolog
y/). MIT Technology Review. Retrieved 7 March 2020.
94. "Gov in the Time of Corona" (https://govinsider.asia/innovation/gov-in-the-time-of-corona/).
GovInsider. 19 March 2020. Archived (https://web.archive.org/web/20200320125215/https://go
vinsider.asia/innovation/gov-in-the-time-of-corona/) from the original on 20 March 2020.
Retrieved 20 March 2020.
95. Manancourt V (10 March 2020). "Coronavirus tests Europe's resolve on privacy" (https://www.
politico.eu/article/coronavirus-tests-europe-resolve-on-privacy-tracking-apps-germany-italy/).
POLITICO. Archived (https://web.archive.org/web/20200320105744/https://www.politico.eu/arti
cle/coronavirus-tests-europe-resolve-on-privacy-tracking-apps-germany-italy/) from the original
on 20 March 2020. Retrieved 20 March 2020.
96. Tidy J (17 March 2020). "Coronavirus: Israel enables emergency spy powers" (https://www.bb
c.com/news/technology-51930681). BBC News. Archived (https://web.archive.org/web/202003
18113608/https://www.bbc.com/news/technology-51930681) from the original on 18 March
2020. Retrieved 18 March 2020.
97. Bünte O (18 March 2020). "Corona-Krise: Deutsche Telekom liefert anonymisierte Handydaten
an RKI" (https://www.heise.de/newsticker/meldung/Corona-Krise-Deutsche-Telekom-liefert-ano
nymisierte-Handydaten-an-RKI-4685191.html) [Corona crisis: Deutsche Telekom delivers
anonymized cell phone data to RKI]. Heise Online (in German). Archived (https://web.archive.o
rg/web/20200324115410/https://www.heise.de/newsticker/meldung/Corona-Krise-Deutsche-Te
lekom-liefert-anonymisierte-Handydaten-an-RKI-4685191.html) from the original on 24 March
2020. Retrieved 25 March 2020.
98. "Moscow deploys facial recognition technology for coronavirus quarantine" (https://www.reuter
s.com/article/us-china-health-moscow-technology-idUSKBN20F1RZ). Reuters. 21 February
2020. Archived (https://web.archive.org/web/20200222215731/https://www.reuters.com/article/
us-china-health-moscow-technology-idUSKBN20F1RZ) from the original on 22 February 2020.
Retrieved 20 March 2020.
99. "Italians scolded for flouting lockdown as death toll nears 3,000" (https://www.post-gazette.co
m/news/world/2020/03/18/Italy-coronavirus-475-deaths-one-day-death-toll-2978-COVID-19-do
ctors/stories/202003180182). Pittsburgh Post-Gazette. Archived (https://web.archive.org/web/2
0200320110555/https://www.post-gazette.com/news/world/2020/03/18/Italy-coronavirus-475-d
eaths-one-day-death-toll-2978-COVID-19-doctors/stories/202003180182) from the original on
20 March 2020. Retrieved 20 March 2020.
00. "Kreative Lösungen gesucht" (https://www.bundesregierung.de/breg-de/themen/coronavirus/wi
r-vs-virus-1731968). Startseite (in German). Archived (https://web.archive.org/web/202003240
85627/https://www.bundesregierung.de/breg-de/themen/coronavirus/wir-vs-virus-1731968)
from the original on 24 March 2020. Retrieved 23 March 2020.
01. Dannewitz J (23 March 2020). "Hackathon Germany: #WirvsVirus" (https://www.datenschutzbe
auftragter-info.de/hackathon-germany-wirvsvirus/). Datenschutzbeauftragter (in German).
02. Staff (8 April 2020). "Lockdown is working, suggests latest data from symptom tracker app" (htt
ps://www.kcl.ac.uk/news/lockdown-is-working-suggests-latest-data-from-symptom-tracker-
app). Kings College London News Centre. Retrieved 20 April 2020.
03. Lydall, Ross (4 May 2020). "Three million download app to track coronavirus symptoms" (http
s://www.standard.co.uk/news/techandgadgets/three-million-download-app-to-track-symptoms-
a4431271.html). Evening Standard. Retrieved 8 May 2020.
04. Whyte A (21 March 2020). "President makes global call to combat coronavirus via hackathon"
(https://news.err.ee/1067171/president-makes-global-call-to-combat-coronavirus-via-hackatho
n). ERR. Archived (https://web.archive.org/web/20200324050421/https://news.err.ee/1067171/
president-makes-global-call-to-combat-coronavirus-via-hackathon) from the original on 24
March 2020. Retrieved 23 March 2020.
05. Xiang YT, Yang Y, Li W, Zhang L, Zhang Q, Cheung T, Ng CH (March 2020). "Timely mental
health care for the 2019 novel coronavirus outbreak is urgently needed" (https://www.ncbi.nlm.
nih.gov/pmc/articles/PMC7128153). The Lancet. Psychiatry. 7 (3): 228–229.
doi:10.1016/S2215-0366(20)30046-8 (https://doi.org/10.1016%2FS2215-0366%2820%293004
6-8). PMC 7128153 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128153).
PMID 32032543 (https://pubmed.ncbi.nlm.nih.gov/32032543).
06. Kang L, Li Y, Hu S, Chen M, Yang C, Yang BX, et al. (March 2020). "The mental health of
medical workers in Wuhan, China dealing with the 2019 novel coronavirus" (https://www.ncbi.n
lm.nih.gov/pmc/articles/PMC7129673). The Lancet. Psychiatry. 7 (3): e14. doi:10.1016/S2215-
0366(20)30047-X (https://doi.org/10.1016%2FS2215-0366%2820%2930047-X).
PMC 7129673 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129673). PMID 32035030 (htt
ps://pubmed.ncbi.nlm.nih.gov/32035030).
07. Coronavirus: 'Profound' mental health impact prompts calls for urgent research (https://www.bb
c.com/news/health-52295894), BBC, Philippa Roxby, 16 April 2020.
08. Multidisciplinary research priorities for the COVID‑19 pandemic: a call for action for mental
health science (https://www.thelancet.com/pdfs/journals/lanpsy/PIIS2215-0366(20)30168-1.pd
f), The Lancet, Emily Holmes, Rory O'Connor, Hugh Perry, et al., 15 April 2020, page 1: "A
fragmented research response, characterised by small-scale and localised initiatives, will not
yield the clear insights necessary to guide policymakers or the public."
09. Roser M, Ritchie H, Ortiz-Ospina E (4 March 2020). "Coronavirus Disease (COVID-19)" (http
s://ourworldindata.org/coronavirus). Our World in Data. Archived (https://web.archive.org/web/
20200319171947/https://ourworldindata.org/coronavirus) from the original on 19 March 2020.
Retrieved 12 March 2020.
10. Yanping Z, et al. (The Novel Coronavirus Pneumonia Emergency Response Epidemiology
Team) (17 February 2020). "The Epidemiological Characteristics of an Outbreak of 2019 Novel
Coronavirus Diseases (COVID-19)—China, 2020" (http://weekly.chinacdc.cn/en/article/id/e539
46e2-c6c4-41e9-9a9b-fea8db1a8f51). China CDC Weekly. Chinese Center for Disease
Control and Prevention. 2 (8): 113–122. Archived (https://web.archive.org/web/202002191421
01/http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51) from the
original on 19 February 2020. Retrieved 18 March 2020.
11. 코로나바이러스감염증-19 국내 발생 현황 (5월 24일) (https://www.cdc.go.kr/board/board.es?mi
d=a20501000000&bid=0015&list_no=367317&act=view) (Report). Korea Centers for Disease
Control and Prevention. 24 May 2020. Retrieved 24 May 2020.
12. Actualización nº 109. Enfermedad por el coronavirus (COVID-19) (https://www.mscbs.gob.es/p
rofesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Actualizacion_109_C
OVID-19.pdf) (PDF) (Report) (in Spanish). Ministerio de Sanidad, Consumo y Bienestar Social.
18 May 2020. Retrieved 20 May 2020.
13. Epidemia COVID-19. Aggiornamento nazionale 14 maggio 2020 (https://www.epicentro.iss.it/c
oronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_14-maggio-2020.pdf) (PDF)
(Report) (in Italian). Rome: Istituto Superiore di Sanità. 15 May 2020. Retrieved 21 May 2020.
14. Roser M, Ritchie H, Ortiz-Ospina E (6 April 2020). "Coronavirus Disease (COVID-19)" (https://
ourworldindata.org/coronavirus). Our World in Data. Retrieved 6 April 2020.
15. Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, et al. (April 2020). "Severe
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and
Adolescents: A Systematic Review" (https://jamanetwork.com/journals/jamapediatrics/fullarticl
e/2765169). JAMA Pediatrics. doi:10.1001/jamapediatrics.2020.1467 (https://doi.org/10.1001%
2Fjamapediatrics.2020.1467). PMID 32320004 (https://pubmed.ncbi.nlm.nih.gov/32320004).
16. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. (April 2020). "SARS-CoV-2 Infection in
Children" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121177). The New England Journal
of Medicine. Massachusetts Medical Society. 382 (17): 1663–1665.
doi:10.1056/nejmc2005073 (https://doi.org/10.1056%2Fnejmc2005073). PMC 7121177 (http
s://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121177). PMID 32187458 (https://pubmed.ncbi.nl
m.nih.gov/32187458).
17. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S (March 2020). "Epidemiology of COVID-19
Among Children in China" (https://pediatrics.aappublications.org/content/pediatrics/early/2020/
03/16/peds.2020-0702.full.pdf) (PDF). Pediatrics: e20200702. doi:10.1542/peds.2020-0702 (ht
tps://doi.org/10.1542%2Fpeds.2020-0702). PMID 32179660 (https://pubmed.ncbi.nlm.nih.gov/
32179660). Archived (https://web.archive.org/web/20200317223427/https://pediatrics.aappubli
cations.org/content/pediatrics/early/2020/03/16/peds.2020-0702.full.pdf) (PDF) from the
original on 17 March 2020. Retrieved 16 March 2020.
18. Fang L, Karakiulakis G, Roth M (April 2020). "Are patients with hypertension and diabetes
mellitus at increased risk for COVID-19 infection?" (https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC7118626). The Lancet. Respiratory Medicine. 8 (4): e21. doi:10.1016/S0140-
6736(20)30311-1 (https://doi.org/10.1016%2FS0140-6736%2820%2930311-1). PMC 7118626
(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118626). PMID 32171062 (https://pubmed.nc
bi.nlm.nih.gov/32171062).
19. "Coronavirus Disease 2019 (COVID-19)" (https://www.cdc.gov/coronavirus/2019-ncov/specific-
groups/children-faq.html). Centers for Disease Control and Prevention (CDC). 11 February
2020. Archived (https://web.archive.org/web/20200302064104/https://www.cdc.gov/coronaviru
s/2019-ncov/specific-groups/children-faq.html) from the original on 2 March 2020. Retrieved
2 March 2020.
20. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. (March 2020). "Dysregulation of immune
response in patients with COVID-19 in Wuhan, China" (https://www.ncbi.nlm.nih.gov/pmc/articl
es/PMC7108125). Clinical Infectious Diseases. doi:10.1093/cid/ciaa248 (https://doi.org/10.109
3%2Fcid%2Fciaa248). PMC 7108125 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC710812
5). PMID 32161940 (https://pubmed.ncbi.nlm.nih.gov/32161940).
21. "WHO Director-General's statement on the advice of the IHR Emergency Committee on Novel
Coronavirus" (https://www.who.int/dg/speeches/detail/who-director-general-s-statement-on-the
-advice-of-the-ihr-emergency-committee-on-novel-coronavirus). World Health Organization
(WHO).
22. Palmieri L, Andrianou X, Barbariol P, Bella A, Bellino S, Benelli E, et al. (3 April 2020).
Characteristics of COVID-19 patients dying in Italy Report based on available data on April
2th, 2020 (https://www.epicentro.iss.it/en/coronavirus/bollettino/Report-COVID-2019_2_april_2
020.pdf) (PDF) (Report). Istituto Superiore di Sanità. Retrieved 3 April 2020.
23. Wang W, Tang J, Wei F (April 2020). "Updated understanding of the outbreak of 2019 novel
coronavirus (2019-nCoV) in Wuhan, China" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC71
67192). Journal of Medical Virology. 92 (4): 441–447. doi:10.1002/jmv.25689 (https://doi.org/1
0.1002%2Fjmv.25689). PMC 7167192 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC716719
2). PMID 31994742 (https://pubmed.ncbi.nlm.nih.gov/31994742).
24. "Coronavirus Age, Sex, Demographics (COVID-19)" (https://www.worldometers.info/coronaviru
s/coronavirus-age-sex-demographics/). www.worldometers.info. Archived (https://web.archive.
org/web/20200227112932/https://www.worldometers.info/coronavirus/coronavirus-age-sex-de
mographics/) from the original on 27 February 2020. Retrieved 26 February 2020.
25. Garg S, Kim L, Whitaker M, O'Halloran A, Cummings C, Holstein R, et al. (April 2020).
"Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed
Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020" (https://www.cdc.gov/
mmwr/volumes/69/wr/mm6915e3.htm). MMWR. Morbidity and Mortality Weekly Report. 69
(15): 458–464. doi:10.15585/mmwr.mm6915e3 (https://doi.org/10.15585%2Fmmwr.mm6915e
3). PMID 32298251 (https://pubmed.ncbi.nlm.nih.gov/32298251).
26. Ji Y, Ma Z, Peppelenbosch MP, Pan Q (April 2020). "Potential association between COVID-19
mortality and health-care resource availability" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC
7128131). The Lancet. Global Health. 8 (4): e480. doi:10.1016/S2214-109X(20)30068-1 (http
s://doi.org/10.1016%2FS2214-109X%2820%2930068-1). PMC 7128131 (https://www.ncbi.nl
m.nih.gov/pmc/articles/PMC7128131). PMID 32109372 (https://pubmed.ncbi.nlm.nih.gov/3210
9372).
27. Li XQ, Cai WF, Huang LF, Chen C, Liu YF, Zhang ZB, et al. (March 2020). "[Comparison of
epidemic characteristics between SARS in2003 and COVID-19 in 2020 in Guangzhou]".
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi (in Chinese). 41 (5):
634–637. doi:10.3760/cma.j.cn112338-20200228-00209 (https://doi.org/10.3760%2Fcma.j.cn1
12338-20200228-00209). PMID 32159317 (https://pubmed.ncbi.nlm.nih.gov/32159317).
28. Jung SM, Akhmetzhanov AR, Hayashi K, Linton NM, Yang Y, Yuan B, et al. (February 2020).
"Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection:
Inference Using Exported Cases" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074479).
Journal of Clinical Medicine. 9 (2): 523. doi:10.3390/jcm9020523 (https://doi.org/10.3390%2Fjc
m9020523). PMC 7074479 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074479).
PMID 32075152 (https://pubmed.ncbi.nlm.nih.gov/32075152).
29. Chughtai AA, Malik AA (March 2020). "Is Coronavirus disease (COVID-19) case fatality ratio
underestimated?" (https://jglobalbiosecurity.com/articles/10.31646/gbio.56/). Global
Biosecurity. 1 (3). doi:10.31646/gbio.56 (https://doi.org/10.31646%2Fgbio.56) (inactive 26 April
2020).
30. Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G (March 2020). "Real estimates of
mortality following COVID-19 infection" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC711851
5). The Lancet. Infectious Diseases. doi:10.1016/S1473-3099(20)30195-X (https://doi.org/10.1
016%2FS1473-3099%2820%2930195-X). PMC 7118515 (https://www.ncbi.nlm.nih.gov/pmc/ar
ticles/PMC7118515). PMID 32171390 (https://pubmed.ncbi.nlm.nih.gov/32171390).
31. Vardavas CI, Nikitara K (20 March 2020). "COVID-19 and smoking: A systematic review of the
evidence" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083240). Tobacco Induced
Diseases. 18 (March): 20. doi:10.18332/tid/119324 (https://doi.org/10.18332%2Ftid%2F11932
4). PMC 7083240 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083240). PMID 32206052
(https://pubmed.ncbi.nlm.nih.gov/32206052).
32. Cheung E (13 March 2020). "Some recovered Covid-19 patients may have lung damage,
doctors say" (https://www.scmp.com/news/hong-kong/health-environment/article/3074988/coro
navirus-some-recovered-patients-may-have). South China Morning Post. Archived (https://we
b.archive.org/web/20200315172445/https://www.scmp.com/news/hong-kong/health-environme
nt/article/3074988/coronavirus-some-recovered-patients-may-have) from the original on 15
March 2020. Retrieved 15 March 2020.
33. Servick K (8 April 2020). "For survivors of severe COVID-19, beating the virus is just the
beginning" (https://www.sciencemag.org/news/2020/04/survivors-severe-covid-19-beating-viru
s-just-beginning). Science. doi:10.1126/science.abc1486 (https://doi.org/10.1126%2Fscience.a
bc1486). ISSN 0036-8075 (https://www.worldcat.org/issn/0036-8075).
34. "Sala de Situación COVID-19 Nuevo Coronavirus 2019 Novedades al 07/05 - 18 hs- SE 19" (h
ttps://www.argentina.gob.ar/sites/default/files/sala_7_mayo.pdf) (PDF) (in Spanish). 7 May
2020.
35. Health, Australian Government Department of (20 May 2020). "COVID-19 cases by age group
and sex" (https://www.health.gov.au/resources/covid-19-cases-by-age-group-and-sex).
Australian Government Department of Health. Retrieved 20 May 2020. Health, Australian
Government Department of (20 May 2020). "COVID-19 deaths by age group and sex" (https://
www.health.gov.au/resources/covid-19-deaths-by-age-group-and-sex). Australian Government
Department of Health. Retrieved 20 May 2020.
36. "Coronavirus Disease 2019 (COVID-19) DAILY EPIDEMIOLOGY UPDATE Updated: 19 May,
2020, 11:00 AM ET" (https://www.canada.ca/content/dam/phac-aspc/documents/services/dise
ases/2019-novel-coronavirus-infection/surv-covid19-epi-update-eng.pdf) (PDF). Public Health
Agency of Canada. 19 May 2020. Retrieved 20 May 2020.
37. "16° informe epidemiológico COVID-19" (https://www.minsal.cl/18-informe-epidemiologico-covi
d-19/). Ministerio de Salud – Gobierno de Chile.
https://cdn.digital.gob.cl/public_files/Campañas/Corona-
Virus/Reportes/17.05.2020_Reporte_Covid19.pdf
38. "Coronavirus Colombia" (https://www.ins.gov.co/Noticias/Paginas/Coronavirus.aspx).
www.ins.gov.co.
39. COVID-19 i Danmark: Epidemiologisk overvågningsrapport den 19. maj 2020 (https://files.ssi.d
k/COVID19-overvaagningsrapport-19052020-d2l8) (Report) (in Danish). Statens Serum
Institut. 19 May 2020. Retrieved 20 May 2020.
40. "Experience" (https://experience.arcgis.com/experience/92e9bb33fac744c9a084381fc35aa3c
7). experience.arcgis.com. https://thl.fi/fi/web/infektiotaudit-ja-
rokotukset/ajankohtaista/ajankohtaista-koronaviruksesta-covid-19/tilannekatsaus-
koronaviruksesta
41. "Coronavirus Disease 2019 (COVID-19) Daily Situation Report of the Robert Koch Institute
21/05/2020 - UPDATED STATUS FOR GERMANY" (https://www.rki.de/DE/Content/InfAZ/N/Ne
uartiges_Coronavirus/Situationsberichte/2020-05-21-en.pdf?__blob=publicationFile) (PDF).
Robert Koch Institute.
42. "‫ משרד הבריאות‬- ‫( "קורונה‬https://t.me/MOHreport/4421?single). Ministry of Health (Israel). 3 May
2020. Retrieved 5 May 2020.
43. "Integrated surveillance of COVID-19 in Italy" (https://www.epicentro.iss.it/en/coronavirus/bollet
tino/Infografica_27maggio%20ENG.pdf) (PDF). Istituto Superiore di Sanità.
44. "Coronavirus Disease (COVID-19) Situation Report in Japan" (https://toyokeizai.net/sp/visual/t
ko/covid19/en). toyokeizai.net.
45. COVID-19 Tablero México - CONACYT (https://coronavirus.gob.mx/datos/) (Report) (in
Spanish). Mexico City: CONACYT. 24 May 2020. Retrieved 24 May 2020.
46. Epidemiologische situatie COVID-19 in Nederland 20 mei 2020 (https://www.rivm.nl/document
en/epidemiologische-situatie-covid-19-in-nederland-20-mei-2020) (Report) (in Dutch).
Bilthoven: Rijksinstituut voor Volksgezondheid en Milie. 20 May 2020. Retrieved 20 May 2020.
47. "COVID-19 Dagsrapport fredag 20. mai 2020" (https://www.fhi.no/contentassets/ca5914bd0aa
14e15a17f8a7d48fa306a/2020.05.20-dagsrapport-norge-covid-19.pdf) (PDF).
Folkehelseinstituttet. 20 May 2020. Retrieved 20 May 2020.
48. https://www.doh.gov.ph/covid19tracker
49. "NOVO CORONAVÍRUS COVID-19 RELATÓRIO DE SITUAÇÃO" (https://covid19.min-saude.
pt/wp-content/uploads/2020/05/79_DGS_boletim_20200520.pdf) (PDF) (in Portuguese). 20
May 2020. Retrieved 20 May 2020.
50. "FOHM Covid-19" (https://experience.arcgis.com/experience/09f821667ce64bf7be6f9f87457ed
9aa). Public Health Agency of Sweden. Retrieved 20 May 2020.
51. "Todesfälle in der Schweiz nach Altersgruppen" (https://datawrapper.dwcdn.net/IJC8v/45).
datawrapper.dwcdn.net. 20 May 2020. Retrieved 20 May 2020.
52. "Case data | Colorado COVID-19 Updates" (https://covid19.colorado.gov/data/case-data).
covid19.colorado.gov.
53. "COVID-19 confirmed cases and deaths by age group | Connecticut Data" (https://data.ct.gov/
Health-and-Human-Services/COVID-19-confirmed-cases-and-deaths-by-age-group/ypz6-
8qyf). data.ct.gov. 20 May 2020. Retrieved 20 May 2020.
54. "Tableau Public" (https://public.tableau.com/profile/idaho.division.of.public.health#!/vizhome/D
PHIdahoCOVID-19Dashboard_V2/Story1). public.tableau.com.
55. "COVID-19 Case Demographics - the Indiana Data Hub" (https://hub.mph.in.gov/dataset/covid-
19-case-demographics). hub.mph.in.gov.
56. "KDPH COVID-19 Dashboard" (https://kygeonet.maps.arcgis.com/apps/opsdashboard/index.ht
ml#/543ac64bc40445918cf8bc34dc40e334). Kygeonet.maps.arcgis.com. Retrieved 21 May
2020.
57. https://coronavirus.maryland.gov Probable but not lab-confirmed deaths not included
58. "COVID-19 Response Reporting" (https://www.mass.gov/info-details/covid-19-response-reporti
ng). Mass.gov. 20 May 2020. Retrieved 20 May 2020.

Potrebbero piacerti anche